Rappta Therapeutics
Pre-clinicalRappta Therapeutics is a lead-optimization stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
Founded
2020
Focus
Small Molecules
About
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
Funding History
1Total raised: $4.2M
Seed$4.2MFinnish Industry InvestmentApr 15, 2022
Company Info
TypePrivate
Founded2020
LocationHelsinki, Finland
StagePre-clinical
Contact
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile